SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: Steve Fancy who wrote (4293)5/12/1998 3:16:00 PM
From: Steve Fancy  Respond to of 6136
 
I bumped my remaining May put positions out to November today. I'm relatively confident that we'll be able to surpass 40 by November. Still holding waaay to much stock also. Next time we hit 36-37, hopefully on the monthly scrip data, I will be selling calls on at least 1/2 of my stock position as a safeguard.

Received a report from PW today - Agouron: Cancer Pipeline Progress...will post it later. It mentions that Phase I/II data will be presented at the 10th NCI-EORTC Symposium on New Drugs in Cancer Therapy scheduled for June 16-19 in Amsterdam.

sf